EOLS

Evolus Stock Analysis

AI Rating

Low
  • Quality7/10
  • Growth 1/10
  • Momentum 1/10
Evolus sales and earnings growth
EOLS Growth
Low
  • Revenue Y/Y 15.10%
  • EPS Y/Y -1.11%
  • FCF Y/Y -124.40%
Evolus gross and profit margin trends
EOLS Profitability
Good
  • Gross margin 65.80%
  • EPS margin -20.50%
  • ROIC -22.30%
Evolus net debt vs free cash flow
EOLS Risk
Great
  • Debt / Equity -5.4
  • Debt / FCF 1.9
  • Interest coverage -1.8

Evolus stock volatility is in-line with the overall market. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗